Showing results (41-50 of 740) with videos related to
Sort By:
Pageof 74
European Journal of Haematology|February 19, 2015
Clinical Course and Prognosis of Non-Secretory Multiple MyelomaSagar S Chawla, Shaji K Kumar, Angela Dispenzieri, et al.European Journal of Haematology|November 11, 2014
Clinical course and prognosis of non-secretory multiple myelomaSagar S Chawla, Shaji K Kumar, Angela Dispenzieri, et al.American Journal of Hematology|October 18, 2021
Chimeric antigen receptor T-cells, bispecific antibodies, and antibody-drug conjugates for multiple myeloma: An updateArjun Lakshman, Shaji K KumarLeukemia & Lymphoma|October 12, 2017
Minimal residual disease analysis in myeloma - when, why and whereUday Yanamandra, Shaji K KumarHematology/Oncology Clinics of North America|January 12, 2024
New Therapies on the Horizon for Relapsed Refractory Multiple MyelomaNadine Abdallah, Shaji K KumarTherapeutic Advances in Hematology|January 7, 2020
Daratumumab in untreated newly diagnosed multiple myelomaNadine Abdallah, Shaji K KumarJournal of the National Comprehensive Cancer Network : JNCCN|November 13, 2024
Up-Front Treatment of Elderly (Age ≥75 Years) and Frail Patients With Multiple MyelomaNadine Abdallah, Shaji K KumarIndian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|June 10, 2017
Highlights of Multiple Myeloma at the Annual Meeting of American Society of Hematology, 2016Nidhi Tandon, Shaji K KumarSeminars in Hematology|January 15, 2011
Development of early treatment strategies for high-risk myeloma precursor disease in the futureOla Landgren, S Vincent RajkumarBest Practice & Research. Clinical Haematology|December 12, 2007
Multiple myeloma: new staging systems for diagnosis, prognosis and response evaluationS Vincent Rajkumar, Francis BuadiPageof 74